Taro Pharmaceutical Industries
NYSE:TARO
| Market Cap (Intraday) | 1.15B |
| Current PE | 17.64 |
| Forward PE | 42.36 |
| 2yr Forward PE | N/A |
| 10-Day MA | $30.59 |
| 50-Day MA | $29.53 |
| 200-Day MA | $33.43 |
Taro Pharmaceutical Industries Stock, NYSE:TARO
14 Hakitor Street, 14 Hakitor Street, Haifa Bay, Haifa 2624761
Phone: +972.4.847.5700
Number of Employees: 1455
Description
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.